Stock Track | Fortrea Soars 10.8% Pre-Market on Strong Q3 Results, Robust Backlog

Stock Track11-08

Shares of Fortrea Holdings Inc. (FTRE) surged 10.8% in pre-market trading on November 8, 2024, after the contract research organization (CRO) reported solid third-quarter results and increased its revenue guidance for the full year.

For the quarter ended September 30, 2024, Fortrea posted revenue of $674.9 million, down slightly from the prior year but in line with expectations. While the company reported a GAAP net loss of $18.5 million, its adjusted EBITDA came in at $64.2 million, indicating underlying profitability.

The highlight of Fortrea's Q3 performance was its robust backlog growth and book-to-bill ratio. The company's backlog grew to $7.57 billion, and its book-to-bill ratio stood at an impressive 1.23x, reflecting strong demand for its clinical trial services. This bodes well for future revenue growth, as the company executes on this backlog.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment